fashion -WSS

fashion

author：leisure time 2025-10-02 03:05:44 - browse：6

The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

“They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： A single Democrat is willing to weaken Medicare negotiation power

WSS

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Updated Covid vaccine has 54% effectiveness, new study suggests

Surgery pushed Ben Carson to fame

European officials brace for rough respiratory virus season

AI gets buy

2023 Nobel Prize in Medicine goes to Karikó and Weissman

hotspot

fashion

focus

Moonlake's readout produced a cash windfall. Risks remain

IVG is promising — but it won’t replace IVF quite yet

Trump demands the U.S. pay no more for drugs than other countries … again

What’s missing from the debate over nursing home staff minimums

Dobbs anniversary: the lost opportunity of abortion as health care

Surgery pushed Ben Carson to fame

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Continuity nursing helped my family in our darkest PICU moments

Stop Congress from blocking public access to science

Wikipedia

Bernie brings in new pharma CEOs to talk drug prices

The Karikó problem: Lessons for funding basic research

Congress extends some pandemic preparedness programs

Study points to new risk in gene therapy death of Terry Horgan

Why Novartis is going to walk from its acquisition of MorphoSys

Adopting new red light myopia treatments may be short

focus

focus

hotspot

hotspot